Autoimmunity

European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus: the laboratory immunologist’s point of view
Maria Infantino, Mariangela Manfredi, Nicola Bizzaro

Annals of the Rheumatic Diseases Nov 2019, annrheumdis-2019-216591; DOI: 10.1136/annrheumdis-2019-216591
The level of peripheral regulatory T cells is linked to changes in gut commensal microflora in patients with systemic lupus erythematosus
Sheng-Xiao Zhang, Jia Wang, Jun-Wei Chen, Ming-Xing Zhang, Yi-Fan Zhang, Fang-Yuan Hu, Zhi-Qin Lv, Chong Gao, Ya-Feng Li, Xiao-Feng Li

Annals of the Rheumatic Diseases Nov 2019, annrheumdis-2019-216504; DOI: 10.1136/annrheumdis-2019-216504
Response to: ‘The level of peripheral regulatory T cells is linked to changes in gut commensal microflora in patients with systemic lupus erythematosus’ by Zhang et al and the phylogeny of a candidate pathobiont in lupus nephritis
Gregg J Silverman, Doua F Azzouz

Annals of the Rheumatic Diseases Nov 2019, annrheumdis-2019-216523; DOI: 10.1136/annrheumdis-2019-216523
M1/M2 polarisation state of M-CSF blood-derived macrophages in systemic sclerosis
Alain Lescoat, Alice Ballerie, Stephane Jouneau, Olivier Fardel, Laurent Vernhet, Patrick Jego, Valérie Lecureur

Annals of the Rheumatic Diseases Nov 2019, 78 (11) e127; DOI: 10.1136/annrheumdis-2018-214333
Immune checkpoint inhibitor rechallenge in patients with immune-related myositis
Julie Delyon, Florence Brunet-Possenti, Sarah Leonard-Louis, Dimitri Arangalage, Mathilde Baudet, Barouyr Baroudjian, Celeste Lebbe, Baptiste Hervier

Annals of the Rheumatic Diseases Nov 2019, 78 (11) e129; DOI: 10.1136/annrheumdis-2018-214336
Titre-specific positive predictive value of antinuclear antibody patterns
Jean-Baptiste Vulsteke, Lieve Van Hoovels, Philippe Willems, Bert Vander Cruyssen, Steven Vanderschueren, Rene Westhovens, Daniel Blockmans, Ellen De Langhe, Xavier Bossuyt

Annals of the Rheumatic Diseases Oct 2019, annrheumdis-2019-216245; DOI: 10.1136/annrheumdis-2019-216245
On the therapeutic scope of low-dose IL-2. Response to: ‘Circulating regulatory T cells were absolutelydecreased in dermatomyositis/polymyositispatients and restored by low-dose IL-2’ by Zhang et al
David Klatzmann

Annals of the Rheumatic Diseases Oct 2019, annrheumdis-2019-216267; DOI: 10.1136/annrheumdis-2019-216267
Response to ‘Titre-specific positive predictive value of anti-nuclear antibody patterns’ by Vulsteke et al
Jan Damoiseaux, Luís Eduardo Coelho Andrade, Marvin J Fritzler, Manfred Herold, Maria Infantino, Carlos von Muhlen

Annals of the Rheumatic Diseases Oct 2019, annrheumdis-2019-216266; DOI: 10.1136/annrheumdis-2019-216266
Difference between SLE classification and diagnosis and importance of attribution. Response to: ‘Do the 2019 EULAR/ACR SLE classification criteria close the door on certain groups of SLE patients?’ by Chi et al
Martin Aringer, Karen H Costenbader, Thomas Dörner, Sindhu R Johnson

Annals of the Rheumatic Diseases Oct 2019, annrheumdis-2019-216338; DOI: 10.1136/annrheumdis-2019-216338
Decreased endothelin receptor A autoantibody levels are associated with early ischaemic events in patients with giant-cell arteritis
Sebastian Klapa, Antje Müller, Andreas Koch, Harald Heidecke, Wataru Kähler, Juliane Junker, Susanne Schinke, Gabriela Riemekasten, Peter Lamprecht

Annals of the Rheumatic Diseases Oct 2019, 78 (10) 1443-1444; DOI: 10.1136/annrheumdis-2019-215341

Main menu

Autoimmunity

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Autoimmunity

Pages